RT Silver

2.2k citations
18 papers · 1.9k · 1 hit paper · h-index 12

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 2%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 10
    • Chronic Myeloid Leukemia Treatments 4
    • Chronic Lymphocytic Leukemia Research 8

RT Silver

18 papers receiving 1.7k citations

RT Silver's Hit Papers

Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study 1982 · 437 citations
4370+14+29Years since publication100200300400

Peers

RT Silver
Comparison fields: 5 of 60
  • Hematology 1.4k
  • Genetics 457
  • Public Health, Environmental and Occupational Health 628
  • Oncology 395
  • Pathology and Forensic Medicine 155
Replace Mario Masi with:
Mario Masi Italy
G Broccia Italy
Susan McKenzie United States
Alain Sadoun France
Pearl Leavitt United States
WJ Miller United States
Marise Weil France
Marcel Hayat France
G A Omura United States
Vlatko Pejša Croatia
RT Silver relative to Mario Masi Italy Mario Masi's profile →
Citations per field
00.5×1.5×2.0×
Mario Masi · 1×
Citations per year

Countries citing papers authored by RT Silver

Since Specialization
Citations

This map shows the geographic impact of RT Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RT Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RT Silver more than expected).

Fields of papers citing papers by RT Silver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RT Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RT Silver. The network helps show where RT Silver may publish in the future.

Co-authors

The 24 scholars most cited alongside RT Silver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with RT Silver Line = papers co-authored together RT Silver links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study
Hit paper breakdown →
1982437
2 1981394
3 1981353
4 1994161
5 1977150
6 1984105
7 198066
8 198256
9 199045
10 198229
11 200119
12 199416
13 197910
14 19849
15 19777
16 19793
17 19822
18 19801

About RT Silver

RT Silver is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology and Rheumatology, having authored 18 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Chronic Lymphocytic Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Chronic Myeloid Leukemia Treatments (4 papers), Glycosylation and Glycoproteins Research (2 papers), Neutropenia and Cancer Infections (2 papers), Advanced Breast Cancer Therapies (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (457 citations), Public Health, Environmental and Occupational Health (628 citations), Oncology (395 citations) and Pathology and Forensic Medicine (155 citations). RT Silver has collaborated with scholars based in United States and Switzerland. Frequent co-authors include KR Rai, CD Bloomfield, Steven George, Doris H. Wurster‐Hill, RK Dodge, R. John Mayer, FR Davey, Andreas Neubauer, CA Schiffer and ED Ball. Their work appears in journals such as Blood and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact